Pulmonary manifestations of immunoglobulin G4-related sclerosing disease

European Respiratory Journal

Volumn 39, Issue 1, 2012, Pages 180-186

  Ryu, J H ^a   Sekiguchi, H ^a   Yi, E S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Immunoglobulin G4; Interstitial lung disease; Lymphadenopathy; Pulmonary inflammation

Indexed keywords

AZATHIOPRINE; BORTEZOMIB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G4; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; RITUXIMAB;

AGE DISTRIBUTION; AUTOIMMUNE PANCREATITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; FIBROSIS; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOGLOBULIN G4 RELATED SCLEROSING DISEASE; INFLAMMATION; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LOW DRUG DOSE; LUNG DISEASE; LUNG FIBROSIS; LUNG PARENCHYMA; MAINTENANCE DRUG DOSE; MEDIASTINITIS; MEDIASTINUM; MULTIPLE ORGAN FAILURE; OPTIMAL DRUG DOSE; PHLEBITIS; PLASMA CELL GRANULOMA; PLEURA; PLEURA DISEASE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE; REVIEW; SEX RATIO; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; LUNG DISEASES; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PNEUMONIA; RISK FACTORS; SCLEROSIS;

EID: 84855362240     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00025211     Document Type: Review

References (50)

1. Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23: 57-66.
2. Zen Y, Nakanuma YL. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol 2010; 34: 1812-1819.
3. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008; 14: 3948-3955.
4. Neild GH, Rodriguez-Justo M, Wall C, et al. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 2006; 4: 23.
5. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Digest Dis Sci 1995; 40: 1561-1568.
6. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-738. (Pubitemid 32204991)
7. Deshpande V, Gupta R, Sainani N, et al. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol 2011; 35: 26-35.
8. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterol 2008; 134: 706-715. (Pubitemid 351312724)
9. Naitoh I, Nakazawa T, Ohara H, et al. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis. Pancreas 2010; 39: e1-e5.
10. Fujinaga Y, Kadoya M, Kawa S, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol 2010; 76: 228-238.
11. Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41: 1197-1205. (Pubitemid 46487210)
12. Stone JH, Khosroshahi A, Deshpande V, et al. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Rare Res 2010; 62: 316-322.
13. Cheuk W, Yuen HKL, Chu SYY, et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 2008; 32: 671-681. (Pubitemid 351600815)
14. Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2009; 33: 1886-1893.
15. Tsushima K, Tanabe T, Yamamoto H, et al. Pulmonary involvement of autoimmune pancreatitis. Eur J Clin Invest 2009; 39: 714-722.
16. Shrestha B, Sekiguchi H, Colby TV, et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol 2009; 33: 1450-1462.
17. Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology 2009; 251: 260-270.
18. Pickartz T, Mayerle J, Lerch MM. Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 314-323. (Pubitemid 47393757)
19. Smyrk TC. Pathological features of IgG4-related sclerosing disease. Curr Opin Rheumatol 2011; 23: 74-79.
20. Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol 2011; 23: 108-113.
21. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58: 1504-1507.
22. Nirula A, Glaser SM, Kalled SL, et al. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 2011; 23: 119-124.
23. Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol 2011; 23: 114-118.
24. Kawa S, Ota M, Yoshizawa K, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002; 122: 1264-1269. (Pubitemid 34465169)
25. Park DH, Kim M-H, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterol 2008; 134: 440-446. (Pubitemid 351173047)
26. Scalapino KJ, Daikh DI. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev 2008; 223: 143-155. (Pubitemid 351986184)
27. Chang M-C, Chang Y-T, Tien Y-W, et al. T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin Chem 2007; 53: 1700-1705. (Pubitemid 47340068)
28. Umemura T, Ota M, Hamano H, et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 2008; 103: 588-594. (Pubitemid 351406007)
29. Umemura T, Ota M, Hamano H, et al. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 2006; 55: 1367-1368. (Pubitemid 44277378)
30. Taniguchi T, Ko M, Seko S, et al. Interstitial pneumonia associated with autoimmune pancreatitis. Gut 2004; 53: 770.
31. Duvic C, Desrame J, Lêvéque C, et al. Retroperitoneal fibrosis, sclerosing pancreatitis and bronchiolitis obliterans with organizing pneumonia. Nephrol Dial Transpl 2004; 19: 2397-2399. (Pubitemid 39214140)
32. Shigemitsu H, Koss MN. IgG4-related interstitial lung disease: a new and evolving concept. Curr Opin Pulm Med 2009; 15: 513-516.
33. Yamashita K, Haga H, Kobashi Y, et al. Lung involvement in IgG4-related lymphoplasmacytic vasculitis and interstitial fibrosis: report of 3 cases and review of the literature. Am J Surg Pathol 2008; 32: 1620-1626.
34. Kobayashi H, Shimokawaji T, Kanoh S, et al. IgG4-positive pulmonary disease. J Thor Imag 2007; 22: 360-362. (Pubitemid 350196960)
35. Hirano K, Kawabe T, Komatsu Y, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J 2006; 36: 58-61. (Pubitemid 43362549)
36. Taniguchi T, Hamasaki A, Okamoto M. A case of suspected lymphocytic hypophysitis and organizing pneumonia during maintenance therapy for autoimmune pancreatitis associated with autoimmune thrombocytopenia. Endocr J 2006; 53: 563-566. (Pubitemid 44351508)
37. Ohara H, Nakazawa T, Sano H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 2005; 31: 232-237. (Pubitemid 41400480)
38. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Human Pathol 2005; 36: 710-717. (Pubitemid 41112024)
39. Takato H, Yasui M, Ichikawa Y, et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med 2008; 47: 291-294. (Pubitemid 351377293)
40. Ito M, Yasuo M, Yamamoto H, et al. Central airway stenosis in a patient with autoimmune pancreatitis. Eur Respir J 2009; 33: 680-683.
41. Inoue M, Nose N, Nishikawa H, et al. Successful treatment of sclerosing mediastinitis with a high serum IgG4 level. Gen Thorac Cardiovas Surg 2007; 55: 431-433. (Pubitemid 47561738)
42. Nakajo M, Jinnouchi S, Fukukura Y, et al. The efficacy of wholebody FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imag 2007; 34: 2088-2095. (Pubitemid 350212140)
43. Hamed G, Tsushima K, Yasuo M, et al. Inflammatory lesions of the lung, submandibular gland, bile duct and prostate in a patient with IgG4-associated multifocal systemic fibrosclerosis. Respirology 2007; 12: 455-457. (Pubitemid 47164767)
44. Yokoyama A, Kondo K, Nakajima M, et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11: 164-168. (Pubitemid 43356896)
45. Al-Salmi QA, Walter JN, Colasurdo GN, et al. Serum KL-6 and surfactant proteins A and D in paediatric interstitial lung disease. Chest 2005; 127: 403-407. (Pubitemid 41724600)
46. Kinoshita F, Hamano H, Harada H, et al. Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT. Respir Med 2004; 98: 1131-1137. (Pubitemid 39317944)
47. Khan ML, Colby TV, Viggiano RW, et al. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk 2010; 10: 217-219.
48. Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62: 1755-1762.
49. Takahashi N, Ghazale AH, Smyrk TC, et al. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 2009; 38: 523-526.
50. Fukui T, Mitsuyama T, Takaoka M, et al. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med 2008; 47: 151-155. (Pubitemid 351372627)